CLINICAL_TRIALS trial_result · 2016-10-25

Clinical Trial Update: Sym004 in Subjects With Stage IV Non-small Cell Lung Cancer [Phase 1]

Phase 1 trial update for Sym004 in stage IV non-small cell lung cancer. The study was terminated and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: EMD Serono | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 1 | Status: TERMINATED | Results posted: 2016-10-25